Codes / ICD10CM / H35.3112

H35.3112 Nonexudative age-related macular degeneration, right eye, intermediate dry stage

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Nonexudative Age-Related Macular Degeneration, Right Eye, Intermediate Dry Stage

Summary

Nonexudative age-related macular degeneration (AMD) is a chronic eye condition affecting the macula, the central part of the retina responsible for sharp central vision. It is characterized by gradual macular deterioration without fluid leakage or bleeding, leading to blurred or reduced vision. This form is commonly referred to as "dry AMD." The intermediate dry stage involves moderate changes, such as larger drusen or pigmentary alterations, with possible mild vision loss.

Causes

The exact cause of nonexudative AMD is not fully understood, but it involves the degeneration of retinal cells and the accumulation of drusen (yellow deposits) under the retina. Oxidative stress and inflammation in retinal tissues are also believed to contribute to the condition.

Risk Factors

  • Increasing age, especially over 50.
  • Family history of macular degeneration.
  • Smoking and tobacco use.
  • Obesity and high cholesterol.
  • Lack of exercise and poor diet lacking antioxidants and zinc.

Symptoms

  • Blurred or reduced central vision in the right eye.
  • Difficulty recognizing faces or reading.
  • Need for brighter lighting when working or reading.
  • Haziness in overall vision.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilation, to assess the macula. Optical coherence tomography (OCT) is used to visualize retinal layers, and an Amsler grid test detects vision distortions. Fundus photography may document drusen and pigmentary changes.

Treatment Options

Treatment focuses on slowing progression and managing symptoms. Options include nutritional supplements (e.g., vitamins C, E, zinc, and lutein), lifestyle modifications, and regular monitoring. No treatments reverse the condition, but early intervention may preserve vision.

Prognosis and Follow-Up

Prognosis varies; intermediate dry AMD may progress to advanced stages over time. Regular follow-up with an eye care provider is essential to monitor changes and adjust care as needed. Vision loss may worsen gradually, but progression is not inevitable.

Complications

Complications include progression to advanced dry AMD (geographic atrophy) or conversion to wet AMD, which involves abnormal blood vessel growth and more severe vision loss. Central vision loss can impact daily activities like reading or driving.

Lifestyle & Prevention

  • Quit smoking and avoid tobacco exposure.
  • Maintain a diet rich in leafy greens, fish, and antioxidants.
  • Exercise regularly and manage weight.
  • Protect eyes from excessive UV light with sunglasses.
  • Monitor vision with an Amsler grid and report changes promptly.

When to Seek Professional Help

Seek care if you experience sudden vision changes, increased blurriness, or distortion in the right eye. Regular eye exams are recommended for those at risk, even without symptoms.

Tips for Medical Coders

Document the eye (right) and stage (intermediate dry) clearly in the medical record. Ensure the diagnosis aligns with clinical findings, such as drusen size or pigmentary changes, to support accurate coding. Use this code only when the stage is confirmed as intermediate dry.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

H35.3112 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.